Osimertinib is a targeted EGFR inhibitor, 3rd Gen, treats EGFR-mutated NSCLC, approved for Ex19Del and L858R mutations, active in brain metastasis.,
Sale!
Lucius
Replica Osimertinib Targeted EGFR inhibitor 3rd Gen NSCLC EGFR Ex19Del/L858R
Original price was: $708.00.$549.00Current price is: $549.00.
Osimertinib is a targeted EGFR inhibitor, 3rd Gen, treats EGFR-mutated NSCLC, approved for Ex19Del and L858R mutations, active in brain metastasis.,